Glucagon receptor antagonism induces increased cholesterol absorption
However, Novo Nordisk, Ozempic's manufacturer, released results from two clinical trials in November 2025 that showed that taking an oral GLP-1 didn't slow disease progression among people with Alzheimer's compared to those who took a placebo
Hansen CF, Vrang N, Sangild PT, Jelsing J
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes variants like GLP1R rs6923761 and GIPR rs1800437 that influence receptor sensitivity and appetite response intensity
Los estudios disponibles sugieren aumentos modestos en los niveles de GLP-1 circulante, sin traducirse consistentemente en prdida de peso clnicamente significativa
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for obesity treatment, offer a clinically relevant model for examining how these processes interact during appetite regulation